Seeing Is Believing
TMCI is currently covered by 5 analysts with an average price target of $4.96. This is a potential upside of $2.51 (8.77%) from yesterday's end of day stock price of $4.56.
Treace Medical Concepts's activity chart (see below) currently has 91 price targets and 84 ratings on display. The stock rating distribution of TMCI is 76.92% HOLD and 23.08% BUY.
Analysts average stock forecasts to be materialized ratio is 36.63% with an average time for these price targets to be met of 64.36 days.
Highest price target for TMCI is $7, Lowest price target is $3, average price target is $4.96.
Most recent stock forecast was given by RICHARD NEWITTER from TRUIST on 10-Aug-2026. First documented stock forecast 18-May-2021.
Currently out of the existing stock ratings of TMCI, 10 are a HOLD (76.92%), 3 are a BUY (23.08%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Jul-2024
$5
$0.21 (4.38%)
$4
Buy Since 31-Dec-2024
$7
$2.54 (56.95%)
$7.5
Hold Since 06-Nov-2024
$3
$-1.46 (-32.74%)
Hold Since 07-Aug-2024
$5.85
$1.39 (31.17%)
$6.5
What is TMCI (Treace Medical Concepts) average time for price targets to be met?
Which analyst has the current highest performing score on TMCI (Treace Medical Concepts) with a proven track record?
Which analyst has the most public recommendations on TMCI (Treace Medical Concepts)?
Which analyst is the currently most bullish on TMCI (Treace Medical Concepts)?
Which analyst is the currently most reserved on TMCI (Treace Medical Concepts)?